Therapeutic advances in psychopharmacology · 2026
Sex, drugs, and arousal-two randomized trials on the effects of ketamine on sexual arousal and calcarine gyrus activity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Klöbl Manfred, Liebe Thomas, Dörl Gregor, Stöhrmann Peter, Schmidt Clemens, Briem Elisa, Milz Christian, Schlosser Gabriel, Kathofer Maximilian, Gomola David, Godbersen Godber Mathis, Crone Julia Sophia, Lanzenberger Rupert, Spies Marie
Аннотация
BACKGROUND: Ketamine, a well-established antidepressant and dissociative anesthetic, is also used recreationally in the club and chemsex scene. Survey and qualitative data suggest that while ketamine facilitates chemsex encounters, it diminishes the intensity of the sexual experience.
OBJECTIVES: To investigate this phenomenon from a neuroscientific perspective while considering ketamine's sex-specific effects.
DESIGN: Two randomized, placebo-controlled crossover studies using intranasal S-ketamine (double-blinded) or intravenous racemic ketamine (single-blinded).
METHODS: Subjective sexual arousal in response to a newly compiled set of erotic stimuli was assessed following subacute S-ketamine and late racemic ketamine administration across two studies. Overall, 67 healthy volunteers (26 females) participated in the studies. Functional magnetic resonance imaging (fMRI) was performed during sexual arousal assessment under late racemic ketamine exposure, with both studies also incorporating resting-state fMRI assessments.
RESULTS: Subacute S-ketamine reduced sexual arousal to heterosexual stimuli in women (β = -0.21, CI95 = (-0.36, -0.06)) and, to a lesser extent, to lesbian stimuli in men (β = -0.16, CI95 = (0.003, -0.33)). It also diminished sexual aversion to gay stimuli in both sexes (β ⩾ 0.18, CI95 ⩾ (0.03, 0.32)). Conversely, late racemic ketamine decreased sexual arousal to heterosexual stimuli in men (β = -0.17, CI95 = (-0.31, -0.02)) while exacerbating sexual aversion to gay stimuli in women (β = -0.24, CI95=(-0.36,-0.12)). Furthermore, late ketamine administration resulted in reduced calcarine gyrus activation in men compared to women, independent of sexual arousal (β ⩽ -0.23, CI95 ⩽ (-0.52, 0.05)). This finding was confirmed for resting activity under subacute ketamine (β = -0.18, CI95 = (-0.32, -0.04)).
CONCLUSION: Our results align with reports of diminished sexual arousal under ketamine, while the reduced sexual aversion may play a role in facilitating chemsex. The heightened sexual aversion in women and the distinct calcarine gyrus activity modulation may relate to previously documented sex-dependent ketamine effects on stress resilience and psychosis-like symptoms.
TRIAL REGISTRATION: Both studies were registered at clinicaltrials.gov: NCT05320120 (2022-04-08), NCT05320107 (2022-04-08).
OBJECTIVES: To investigate this phenomenon from a neuroscientific perspective while considering ketamine's sex-specific effects.
DESIGN: Two randomized, placebo-controlled crossover studies using intranasal S-ketamine (double-blinded) or intravenous racemic ketamine (single-blinded).
METHODS: Subjective sexual arousal in response to a newly compiled set of erotic stimuli was assessed following subacute S-ketamine and late racemic ketamine administration across two studies. Overall, 67 healthy volunteers (26 females) participated in the studies. Functional magnetic resonance imaging (fMRI) was performed during sexual arousal assessment under late racemic ketamine exposure, with both studies also incorporating resting-state fMRI assessments.
RESULTS: Subacute S-ketamine reduced sexual arousal to heterosexual stimuli in women (β = -0.21, CI95 = (-0.36, -0.06)) and, to a lesser extent, to lesbian stimuli in men (β = -0.16, CI95 = (0.003, -0.33)). It also diminished sexual aversion to gay stimuli in both sexes (β ⩾ 0.18, CI95 ⩾ (0.03, 0.32)). Conversely, late racemic ketamine decreased sexual arousal to heterosexual stimuli in men (β = -0.17, CI95 = (-0.31, -0.02)) while exacerbating sexual aversion to gay stimuli in women (β = -0.24, CI95=(-0.36,-0.12)). Furthermore, late ketamine administration resulted in reduced calcarine gyrus activation in men compared to women, independent of sexual arousal (β ⩽ -0.23, CI95 ⩽ (-0.52, 0.05)). This finding was confirmed for resting activity under subacute ketamine (β = -0.18, CI95 = (-0.32, -0.04)).
CONCLUSION: Our results align with reports of diminished sexual arousal under ketamine, while the reduced sexual aversion may play a role in facilitating chemsex. The heightened sexual aversion in women and the distinct calcarine gyrus activity modulation may relate to previously documented sex-dependent ketamine effects on stress resilience and psychosis-like symptoms.
TRIAL REGISTRATION: Both studies were registered at clinicaltrials.gov: NCT05320120 (2022-04-08), NCT05320107 (2022-04-08).